A rapid method for determining the reaction progress in the preparation process of doxycycline hydrochloride using HPLC with the hydrogenation reaction solution as the detection target.
By employing a dedicated HPLC column and isocratic elution with the mobile phase, the problems of low sensitivity and poor reproducibility of the doxycycline hydrochloride hydrogenation reaction solution were solved. This enabled rapid and accurate monitoring of the reaction process and control of impurities, thereby improving the production quality and stability of doxycycline hydrochloride.
Patent Information
- Application Number
- CN202611579678.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-10-13
- Publication Date
- 2026-11-10
AI Technical Summary
In the existing technology, the process monitoring method for doxycycline hydrochloride hydrogenation reaction solution has low sensitivity and poor reproducibility, and cannot achieve accurate quantitative and synchronous monitoring of the conversion of main components and the generation of key impurities, making it difficult to meet the quality control requirements of industrial production.
The HPLC method was used with an octadecyl-bonded silica column based on ultra-high purity spherical porous silica as the matrix. The elution was carried out with a dedicated C18 column and buffer salt organic mobile phase with isocratic elution. Combined with 280 nm ultraviolet wavelength detection, the separation and quantification of doxycycline, 6-epidoxycycline and methacycline were achieved. The reaction progress was determined in real time by the changes in component content.
It enables rapid and accurate monitoring of the hydrogenation reaction of doxycycline hydrochloride, reducing the detection time to 10 minutes. It has high sensitivity and good reproducibility, and can accurately quantify the content of doxycycline and impurities, meeting the ICH Q2(R1) and USP verification requirements, thus improving the stability of industrial production and product quality.
Smart Images

Figure CN123066271A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of pharmaceutical analysis technology, specifically relating to a method for rapidly determining the reaction progress of doxycycline hydrochloride preparation process using HPLC with hydrogenation reaction solution as the detection target. Background Technology
[0002] Doxycycline hydrochloride, also known as doxycycline, is a tetracycline broad-spectrum antibiotic. It is characterized by its broad antibacterial spectrum, good oral absorption, long half-life, and wide clinical application, making it an important anti-infective drug for both human and veterinary use. In the industrial production process of doxycycline hydrochloride, the hydrogenation reaction is a key step determining the purity, yield, and quality of the product. During the reaction, key intermediates and byproducts such as 6-epidoxycycline and methacycline are generated (data source: CN115028546A A method for preparing doxycycline sulfosalicylate by hydrogenation of methacycline p-toluenesulfonate; CN108440330A A method for preparing doxycycline hydrochloride). Changes in their content directly reflect the reaction progress, degree of conversion, and endpoint control effectiveness.
[0003] Currently, most pharmaceutical companies in China still commonly use thin-layer chromatography (TLC) to monitor the process of doxycycline hydrochloride hydrogenation reaction solution. Although this method is simple to operate, it has obvious drawbacks: long detection time, limited separation effect, and inability to achieve accurate quantification; it can only make semi-quantitative judgments based on spot depth, resulting in low sensitivity and poor reproducibility; it is difficult to meet the GMP requirements for accurate, traceable, and quantifiable process control data, and it cannot achieve simultaneous and accurate monitoring of impurities such as 6-epidoxycycline and methacycline.
[0004] In existing literature and pharmacopoeia methods, high-performance liquid chromatography (HPLC) is mostly used for related substance testing of doxycycline hydrochloride products. Its chromatographic conditions, sample pretreatment, and system suitability requirements are all designed for the final product and are not suitable for the complex matrix of the hydrogenation reaction solution, resulting in problems such as numerous interfering peaks, insufficient resolution, and large quantitative errors. Meanwhile, a dedicated HPLC detection method specifically designed for the hydrogenation reaction solution control scenario, capable of simultaneously monitoring the conversion of the main component and the formation of key impurities, and with complete methodological validation, has not yet been publicly reported.
[0005] Therefore, developing a rapid, accurate, and quantitative detection method for doxycycline hydrochloride hydrogenation reaction solution that is highly specific, sensitive, precise, has a wide linear range, meets ICH Q2(R1) and USP validation requirements, and is applicable to real-time monitoring of reaction progress, determination of reaction endpoint, calculation of raw material conversion rate, and control of impurity levels is of great significance for improving the stability of industrial production and ensuring product quality. Summary of the Invention
[0006] The technical problem solved by this invention is to provide a method for rapidly determining the reaction progress of doxycycline hydrochloride preparation process using HPLC with hydrogenation reaction solution as the detection target. This method has strong specificity, high sensitivity, good precision and excellent linearity, and can simultaneously and accurately quantify doxycycline hydrochloride, 6-epidoxycycline and methacycline, effectively overcoming the shortcomings of traditional thin-layer chromatography methods such as long time consumption, inaccurate quantification and poor reproducibility.
[0007] To solve the above-mentioned technical problems, the technical solution adopted by the present invention is as follows:
[0008] A rapid HPLC method for determining the reaction progress in the preparation of doxycycline hydrochloride using the hydrogenation reaction solution as the detection target is disclosed. The method targets doxycycline, 6-epidoxycycline, and methacycline in the doxycycline hydrochloride hydrogenation reaction solution. An octadecyl-bonded silica column with ultra-high purity spherical porous silica as the matrix is used, with isocratic elution using a single mobile phase. The mobile phase is prepared as follows: ammonium acetate and disodium ethylenediaminetetraacetate are weighed at a mass ratio of 5-6:1, dissolved in 3300 mL of 0.01 M HCl, followed by the addition of 30 mL of triethylamine and 555 mL of acetonitrile. The pH is adjusted to 9.07 with glacial acetic acid, and the mixture is filtered through a mixed microporous membrane. The mobile phase achieves separation of the three target components within 10 minutes, and the hydrogenation reaction progress is determined in real time by changes in component content.
[0009] Furthermore, when the percentage of metacycline in the hydrogenation reaction solution is ≤0.20%, the hydrogenation reaction is considered to have reached the endpoint and is terminated. If the percentage of metacycline is >0.20%, the hydrogenation reaction continues, and the reaction time is extended accordingly based on the residual metacycline content, and then retested until the percentage of metacycline is ≤0.20%.
[0010] Furthermore, the retesting process after extending the reaction time is as follows: for metacycline content of 0.2%~0.5%, extend the reaction time by 1 hour; for metacycline content of 0.5%~1.5%, extend the reaction time by 2 hours; for metacycline content of 1.5%~2.5%, extend the reaction time by 3 hours; for metacycline content >2.5%, continue the reaction and resample for retesting.
[0011] Furthermore, the method for rapidly determining the reaction progress of doxycycline hydrochloride preparation using HPLC with the hydrogenation reaction solution as the detection target includes the following steps:
[0012] 1) Prepare the test solution and set aside;
[0013] 2) Set up liquid chromatography conditions using an octadecyl-bonded silica column with ultra-high purity spherical fully porous silica as the matrix, and perform isocratic elution; wherein, the mobile phase is prepared as follows: weigh ammonium acetate and disodium ethylenediaminetetraacetate at a mass ratio of 5~6:1, add 3300mL of 0.01M HCl, dissolve, add 30mL of triethylamine, add 555mL of acetonitrile, add 2.5mL of glacial acetic acid to adjust the pH to 9.07 at room temperature, mix, and filter with a 0.45μm organic phase / aqueous phase compatible mixed microporous membrane;
[0014] 3) Accurately measure the test solution, inject it into the liquid chromatograph, and record the chromatogram.
[0015] Further, in step 1), the test solution is prepared as follows: 20 mg of hydrogenation reaction solution is transferred to a 50 mL volumetric flask, 0.5 mL of acetonitrile and 5 mL of 0.01 M HCl are added and dissolved by ultrasonication, and then diluted to volume with 0.01 M HCl.
[0016] Furthermore, in step 2), the chromatographic column is a Zafex Luxthylfex XT-C18 with a size of 250×4.6mm and a packing particle size of 5μm.
[0017] Furthermore, in step 2), the column temperature is 45°C and the flow rate is 1.0 mL / min.
[0018] Furthermore, in step 2), the detection wavelength is 280nm.
[0019] Furthermore, in step 2), the injection volume is 20 μL.
[0020] Furthermore, the linear regression equation for doxycycline in the concentration range of 20%–120% is y = 590.5743x - 1.1609, with a correlation coefficient R0. 2 ≥0.999.
[0021] Compared with the prior art, the present invention has the following advantages:
[0022] (1) The present invention uses reversed-phase high performance liquid chromatography, selects a special C18 column and isocratic elution with buffer salt organic mobile phase, and detects at 280 nm ultraviolet wavelength; prepare mixed reference standard and reaction solution of acetonitrile-hydrochloric acid for test sample by ultrasonic dissolution, and separate doxycycline, 6-epidoxycycline and methacycline according to the polarity difference of components, quantify by external standard method, and monitor hydrogenation reaction and determine reaction endpoint by relying on the change of impurity content.
[0023] (2) The entire methodology of this invention complies with ICH requirements. The separation and peak shape of the three target analytes are good, the detection sensitivity is high, and the linearity of doxycycline is high. 2The result was 0.9998, and the repeatability and intermediate precision RSD were both less than 1.0%. Sampling throughout the hydrogenation process showed that methacycline was consumed with the reaction and 6-epidoxane continued to increase, which could accurately locate the reaction endpoint. Moreover, compared with many chromatographic columns, only the separation effect of the conditions of this invention was the best, and the result was obtained in only 15 minutes for a single detection.
[0024] (3) Compared with traditional thin-layer chromatography, this method can accurately quantify and trace data, avoiding errors in visual interpretation; compared with the product-specific liquid chromatography method, this scheme is suitable for complex matrices in hydrogenation reactions, and the acquisition and elution time of high-performance liquid chromatography is shortened from 50~60min to 10min, and the complete central control detection process is only about 15min; compared with the ordinary C18 chromatography system, the dedicated chromatographic column with optimized parameters has a more stable separation effect, and can shorten the high temperature and pressure time of palladium on carbon catalyst, reduce the cost of production consumables, and is suitable for industrial central control batch detection. Attached Figure Description
[0025] Figure 1 This is the chromatogram of the reference solution in this application;
[0026] Figure 2 The chromatogram of the hydrogenation reaction solution used in this application is shown below.
[0027] Figure 3 This is a linear standard curve diagram for this application;
[0028] Figure 4 High-performance liquid chromatogram of the reference solution on an Xbridge R C18 (4.6×150mm, 5μm) column;
[0029] Figure 5 High-performance liquid chromatogram of the reference solution on an Ultimate C18 (4.6×250mm, 5μm) column;
[0030] Figure 6 High-performance liquid chromatogram of the reference solution on a Superfex PB.C18 (4.6×150mm, 5μm) column;
[0031] Figure 7 The high-performance liquid chromatogram of the reference solution is shown on a short-column C18 (4.6×150mm, 5μm) column.
[0032] Figure 8 High-performance liquid chromatogram of reference solution on Zafex Luxthylfex XT-C18 (4.6×250mm, 5μm) column. Detailed Implementation
[0033] The present invention will be further illustrated below with reference to specific embodiments. These embodiments are implemented based on the technical solutions of the present invention, and it should be understood that these embodiments are only used to illustrate the present invention and are not intended to limit the scope of the present invention.
[0034] Information on the standard products used in the following examples is shown in Table 1 below.
[0035] Table 1 Standard Product Information
[0036]
[0037] Preparation method of hydrogenation reaction solution: 500 kg of 11a-chloro-6-methyleneoxytetracycline p-toluenesulfonate was added to a high-pressure hydrogenation reactor, 1000 L of methanol / ethanol mixed solvent was added and stirring was started, 40 kg of palladium on carbon catalyst and 5 kg of auxiliary agent were added, the reactor was sealed and purged with nitrogen three times, and then hydrogen was introduced. The hydrogen pressure was maintained at 0.35 MPa, the temperature was controlled at 45℃ and the hydrogenation and dechlorination reaction was continued. After the reaction was completed, the pressure was released, nitrogen was purged, and the solid palladium on carbon catalyst was removed by filtration. The filtrate obtained is the hydrogenation reaction solution of crude doxycycline hydrochloride.
[0038] The following are methods for preparing sample solutions:
[0039] Reference solution (a): Accurately weigh 10 mg of 6-epidoxycycline standard into a 50.0 mL volumetric flask, and dilute to the mark with 0.01 M HCl, labeling it as 1. # .
[0040] Reference solution (b): Accurately weigh 10 mg of methacycline standard into a 50.0 mL volumetric flask, and dilute to the mark with 0.01 M HCl, labeling it as 2. # .
[0041] Reference solution (c): Accurately weigh 10 mg of doxycycline standard into a 50.0 mL volumetric flask, and dilute to the mark with 0.01 M HCl, labeling it as 3. # .
[0042] Reference solution: Accurately pipette 2 mL of reference solution (a), 2 mL of reference solution (b), and 2 mL of reference solution (c) into a 25.0 mL volumetric flask, and dilute to the mark with 0.01 M HCl, labeling as 4. # .
[0043] Test solution: Transfer 1 drop (about 20 mg) of hydrogenation reaction solution into a 50 mL volumetric flask, add 0.5 mL of acetonitrile and 5 mL of 0.01 M HCl, sonicate to dissolve, and make up to volume with 0.01 M HCl.
[0044] Blank solution: 0.01M HCl solution.
[0045] Example 1
[0046] A rapid method for determining the reaction progress in the preparation process of doxycycline hydrochloride using HPLC with the hydrogenation reaction solution as the detection target includes the following steps:
[0047] (1) The instrument used was HPLC (Shimadzu LC-2030C).
[0048] (2) Setting up liquid chromatography conditions: the column was a Zafex Luxthylfex XT-C18 (250×4.6mm, 5μm); the column temperature was 45℃; the flow rate was 1.0mL / min; the detection wavelength was 280nm; the injection volume was 20uL; the run time was 10min; and isocratic elution was used.
[0049] Mobile phase: Weigh 59.55g ammonium acetate and 11.1672g disodium ethylenediaminetetraacetate, add 3300mL 0.01M HCl, dissolve, add 30mL triethylamine, add 555mL acetonitrile, add 2.5mL glacial acetic acid to adjust pH to 9.07 at room temperature, mix, and filter with a 0.45μm organic / aqueous phase compatible mixed microporous membrane.
[0050] (3) Sample detection method: Accurately pipette 20 µL of the reference solution and the test solution respectively, inject them into the liquid chromatograph, and record the chromatograms. Results are shown in […]. Figure 1-2 .
[0051] Depend on Figure 1-2 Chromatogram ( Figure 2 The hydrogenation reaction solution used in the test sample was obtained from a reaction time of 5.5 hours. As can be seen from the comparison, the peaks of the three components in the reference solution were clearly separated without interference. The hydrogenation reaction solution sample can simultaneously detect the raw material intermediates and by-products, thereby forming simultaneous quantitative detection results for doxycycline, 6-epidoxycycline, and methacycline, which are used to accurately determine the endpoint of the hydrogenation reaction. The chromatographic acquisition time is only 10 minutes, and the complete detection process, including sample pretreatment, instrument balancing, injection, and chromatographic acquisition, can produce the judgment result in about 15 minutes.
[0052] Example 2
[0053] The detection method of Example 1 was validated in terms of specificity, system suitability, limit of quantitation, linearity, repeatability, and intermediate precision.
[0054] 1. Exclusivity
[0055] Specific solution: Accurately pipette 2 mL of reference solution (a) into a 25.0 mL volumetric flask, and dilute to the mark with 0.01 M HCl, marking it as 5. #Solution. Accurately pipette 2 mL of reference solution (b) into a 25.0 mL volumetric flask, and dilute to the mark with 0.01 M HCl, marking it as 6. # Solution. Accurately pipette 2 mL of reference solution (c) into a 25.0 mL volumetric flask, and dilute to the mark with 0.01 M HCl, marking it as 7. # Solution.
[0056] Under the detection conditions of Example 1, one injection of each specific solution and five injections of the reference solution were performed. The retention times, theoretical plate numbers, resolutions between adjacent peaks, and RSDs of the peak areas of the five reference solutions were recorded for metazidine, 6-epidoxycycline, and doxycycline, respectively. The results are shown in Tables 2-3.
[0057] Table 2 Specificity Test Results
[0058]
[0059] Table 3 Test results of reference solution
[0060]
[0061] As shown in Table 2-3, the chromatographic peaks of each single impurity component are symmetrical, with symmetry factors ranging from 0.95 to 0.97, and theoretical plate numbers all exceeding 6600. The retention times of the three components are clearly distinguishable and do not interfere with each other, indicating excellent method specificity. The RSD of the peak area of the reference solution after five consecutive injections is 0.59%, far below the control limit of 1.0%, and the chromatographic response is stable, indicating good method repeatability.
[0062] 2. Limit of Quantification and Limit of Detection
[0063] Take 4g of the reference solution # The solution was gradually diluted, and the diluted solution was measured under the detection conditions. The limit of quantitation (LOQ) concentration was determined at a signal-to-noise ratio of 10 ± 1, and the limit of detection (LOD) concentration was determined at a signal-to-noise ratio of 3 ± 1. The results are shown in Table 4.
[0064] Table 4 Results of Limit of Quantitation and Limit of Detection
[0065]
[0066] As shown in Table 4, the detection limits of the three components, methacycline, 6-epidoxycycline, and doxycycline, are as low as 0.0039 μg / mL, and the quantitation limits are as low as 0.016 μg / mL. The signal-to-noise ratios of each component are all within the specified limits, which can sensitively detect trace impurities in the sample. This indicates that the quantitation and detection limits of the related substances in this method are low and the sensitivity is excellent.
[0067] 3. Linear relationship
[0068] Accurately weigh 200 mg of doxycycline and place it in a 100 mL volumetric flask. Dissolve and dilute to the mark with 0.01 M HCl, shake well, and label as 8. # Solution. Accurately pipette 8 μL of each solution. # 1.0 mL, 2.0 mL, 3.0 mL, 5.0 mL, and 6.0 mL of the solution were poured into 25 mL volumetric flasks to prepare standard solutions containing 0.08 mg / mL, 0.16 mg / mL, 0.24 mg / mL, 0.4 mg / mL, and 0.48 mg / mL of doxycycline, respectively. These solutions were then injected under the specified assay conditions. The results are shown in Table 5. Figure 3 .
[0069] Table 5 Results of Linear Experiments
[0070]
[0071] From Table 5 and Figure 3 It can be seen that, for doxycycline in the concentration range of 20% to 120%, a standard curve was established with concentration as the x-axis and peak area as the y-axis. The regression equation was y = 590.5743x - 1.1609, and the correlation coefficient R was [missing value]. 2 =0.9998, which is greater than the acceptable standard of 0.999. The peak area at each concentration point shows a high degree of linear matching with the concentration change, proving that the method has a good linear correlation.
[0072] 4. Repeatability
[0073] Repeatable solution: Transfer 1 drop (about 20 mg) of hydrogenation reaction solution into a 50 mL volumetric flask, add 0.5 mL of acetonitrile and 5 mL of 0.01 M HCl and sonicate to dissolve. Make up to volume with 0.01 M HCl to prepare 6 parallel solutions.
[0074] Reference solution 4 # Five injections were performed, and six reproducible solutions were prepared in parallel and injected once for each solution. The results were determined using the external standard method, and the results are shown in Tables 6-7.
[0075] Table 6 Repeatability test results
[0076]
[0077] Table 7. Repeatability test results of doxycycline, methacycline, and 6-tabledoxycycline.
[0078]
[0079] As shown in Table 6-7, the RSD of the peak area of the reference standard after 5 consecutive injections was 0.30%, and the RSD of the peak area of doxycycline in 6 repeatability solutions was 0.33% and the RSD of the peak area of 6-epidoxane was 0.94%, all of which were less than the limit of 1.0%. Metacycline was not detected. The fluctuation of each detection data was small, indicating that the method has excellent repeatability.
[0080] 5. Intermediate precision
[0081] With different operators, on different test dates, using different liquid chromatography instruments, and referring to the test methods under the repeatability section, the same batch of hydrogenation reaction solution samples were tested for relevant substances. The results are shown in Tables 8-9.
[0082] Table 8 Results of intermediate precision test
[0083]
[0084] Table 9. Results of intermediate precision tests for doxycycline, methacycline, and 6-epidoxycycline.
[0085]
[0086] As shown in Tables 8-9, under different operators, different test dates, and different liquid chromatography instruments, the RSD of the peak area of the reference standard was 0.16%, the RSD of the peak area of doxycycline in the 6 intermediate precision solutions was 0.14%, and the RSD of the peak area of 6-epidoxycycline was 0.58%, all of which were less than the limit requirement of 1.0%. Metformin in the samples was not detected, and the detection results showed small deviation, indicating that the method has good intermediate precision and excellent overall detection stability.
[0087] Example 3
[0088] Referring to the detection method in Example 1, the chromatographic column was replaced with 4 control solutions. # The solution was tested, among which... Figure 4-8 The reaction time of the hydrogenation reaction solution in the sample used in the chromatographic column was 7 hours. The results are shown in Table 10 and 10. Figure 4-8 .
[0089] Table 10 Detection results of different chromatographic columns
[0090]
[0091] Depend on Figure 4-8Tests using different chromatographic columns revealed that Xbridge R-C18, Ultimate C18, Supperfex-PB.C18, and ordinary C18 columns could not achieve rapid peak elution of methacycline, 6-epidoxycycline, and doxycycline, exhibiting defects such as peak overlap, peak broadening, and insufficient resolution. However, when using only the Zafex-Luxthylfex-XT-C18 column, with a chromatographic acquisition time of 10 minutes and a chromatographic abscissa acquisition range of 0–10 minutes, the three components could be effectively separated with symmetrical peak shapes, meeting the system applicability requirements for the central control detection of hydrogenation reaction solutions.
[0092] Example 4
[0093] Using the detection method described in Example 1 of this application, samples of the hydrogenation reaction solution were taken at different reaction time periods of 3 to 10 hours. After preparing test solutions, the samples were injected for detection. The changes in the contents of metacycline, 6-epidoxycycline, and doxycycline in the hydrogenation reaction solution were monitored in real time. When the test results showed that the intermediate metacycline was completely undetectable, the hydrogenation reaction was immediately stopped, the reaction termination time was recorded, and the content of each component in the resulting hydrogenation reaction solution was determined. The results are shown in Table 11.
[0094] Table 11 Sampling test results at different reaction time periods
[0095]
[0096] As shown in Table 11, the detection method of this application, which monitors the hydrogenation reaction in real time and terminates the reaction in time when tacycline (less than 0.20%), can effectively inhibit the formation of the byproduct 6-epidoxane, and the 6-epidoxane impurity in the hydrogenation reaction solution is at a low level. At the same time, it shortens the residence time of the palladium-on-carbon catalyst under high temperature and high pressure conditions, reduces catalyst loss, and results in a higher quality hydrogenation solution product.
[0097] Example 5
[0098] Instead of using the liquid chromatography detection method of this application, the reaction endpoint was determined solely based on the amount of hydrogen absorbed during the hydrogenation process. This method is highly inaccurate and has low feasibility, as the actual hydrogen absorption in a typical hydrogenation reaction is 95-105% of the theoretical value. When the hydrogen absorption reached 95% of the theoretical value, a sample was taken to detect the methanocycline content in the reaction solution. The original hydrogenation temperature and pressure conditions were maintained for an extended reaction time of 2 hours, and a sample was taken again. The detection method of Example 1 of this application was used to determine the contents of methanocycline, 6-epidoxycycline, and doxycycline in the hydrogenation reaction solution. The results are shown in Table 12.
[0099] Table 12 Results of rapid liquid chromatography analysis after sampling based on hydrogen absorption capacity
[0100]
[0101] As shown in Table 12, relying solely on hydrogen absorption to determine the reaction endpoint is inaccurate, with some batches still retaining 5-10% methacin. In some batches, extending the hydrogen absorption time after reaching the target is pointless, leading to over-reaction and a significant increase in the content of the byproduct 6-epidoxane. Furthermore, prolonged exposure of the palladium-on-carbon catalyst to high temperature and pressure increases catalyst loss, and its activity decreases during recycling.
[0102] Example 6
[0103] Five sets of experiments were conducted according to the preparation process of doxycycline hydrochloride. The parameters of raw material input, solvent ratio, palladium-on-carbon catalyst dosage, reaction temperature, pressure, and post-treatment salt crystallization and drying were kept consistent. Hydrogenation reaction solutions with different impurity levels were obtained by controlling the endpoint of the hydrogenation reaction. The process included the following steps:
[0104] 1) 500 kg of 11a-chloro-6-methyleneoxytetracycline p-toluenesulfonate was added to a high-pressure hydrogenation reactor, along with 1000 L of methanol / ethanol mixed solvent. Stirring was started, and 40 kg of palladium catalyst on carbon and 5 kg of auxiliary agent were added. After the reactor was purged with nitrogen three times, hydrogen was introduced to maintain a hydrogen pressure of 0.35 MPa and a temperature of 45 °C for 10 h of hydrogenation and dechlorination reaction. After the reaction was completed, the pressure was released, nitrogen was purged, and the palladium catalyst on carbon was removed by filtration to obtain the hydrogenation reaction solution.
[0105] 2) Take the obtained hydrogenation reaction solution, add 220 kg of sulfosalicylic acid methanol / ethanol solution, and carry out the salt formation reaction at room temperature; stir and crystallize at room temperature, filter under vacuum, and wash with cold methanol / ethanol mixed solvent to obtain 350.8 kg of hydrogenated salt.
[0106] 3) The above-mentioned hydrogenated salt was mixed with 100 kg of 30% hydrogen chloride-ethanol solution, heated and stirred until the system was clear, cooled to room temperature and stirred for 5 h to crystallize, filtered and washed, and dried under vacuum at 50 °C to obtain doxycycline hydrochloride product.
[0107] Samples of hydrogenation reaction solution, hydrogenated salt intermediate, and final doxycycline hydrochloride were collected from each group. The hydrogenation reaction solution and hydrogenated salt were tested under the detection conditions of Example 1 of this application. The doxycycline hydrochloride product was tested under the liquid chromatography conditions of the doxycycline hydrochloride section of the Pharmacopoeia of the People's Republic of China. The contents of medahaloxycycline and 6-epidoxycycline impurities in each sample were quantitatively determined. The results of the five parallel tests are shown in Table 13.
[0108] Table 13 Detection results of intermediates and finished products throughout the entire process
[0109]
[0110] As shown in Table 13, the process conditions of the five parallel preparation experiments were completely consistent. The hydrogenation reaction solution and the hydrogenated salt were detected by the rapid liquid chromatography method of this application, and then the finished doxycycline hydrochloride was detected by the pharmacopoeia method. The methacycline and 6-epidocycycline impurities in the hydrogenation reaction solution and the hydrogenated salt can be transferred to the finished product. The impurity detection data of the intermediates and the finished product of the five parallel samples showed little fluctuation, indicating that the entire preparation process has good repeatability. At the same time, it verified that the intermediate impurity level detected by the rapid liquid chromatography method of this application can effectively predict the impurity situation of the final product. It can be used for the quality control of intermediates in the entire process of industrial production of doxycycline hydrochloride and can control the quality risks of the finished product in advance.
[0111] Example 7
[0112] The reaction endpoint is predicted based on the amount of hydrogen absorbed. If the hydrogen absorption is not obvious and the hydrogen absorption reaches 97% of the predetermined value, the initial sampling of the hydrogenation reaction solution is performed after an extension of 1 hour, or after reaching 93% and an extension of 2 hours. For cases where the reaction endpoint has not been reached (metacycline content <0.2%) when the reaction solution is sampled for the first time, the following scheme is designed as shown in Table 14.
[0113] Table 14 Correspondence between metacycline residue and reaction extension time
[0114]
[0115] Based on the initial sampling results, if the tacycline content is <2.5%, extend the hydrogenation reaction time according to the time requirements in the table above, then directly separate the hydrogenation reaction liquid and the catalyst, and crystallize the reaction liquid. If the initial sampling result is >2.5%, continue the reaction for 3 hours and then resample for testing and determination.
[0116] Multiple batches of process validation were carried out using the closed-loop strategy of sampling-time compensation-retesting described above, and the validation results are shown in Table 15.
[0117] Table 15 Sampling test results after extended reaction based on methacin detection results
[0118]
[0119] As shown in Table 15, the above scheme avoids unnecessary extension of the hydrogenation reaction time and ensures very stable product quality control. The impurities in doxycycline are consistently controlled to less than 0.2%, which can be used to control the endpoint of the hydrogenation reaction when producing high-quality doxycycline hydrochloride. The above verification results indicate that, except for batch 3, the other batches do not require secondary sampling and can guarantee that the products meet high-quality requirements.
[0120] The above description is only a preferred embodiment of the present invention. It should be noted that for those skilled in the art, several improvements and modifications can be made without departing from the principle of the present invention, and these improvements and modifications should also be considered within the scope of protection of the present invention.
Claims
1. A method for rapidly determining the reaction progress in the preparation process of doxycycline hydrochloride using HPLC with the hydrogenation reaction solution as the detection target, characterized in that, Doxycycline, 6-epidoxycycline, and methacycline in the doxycycline hydrochloride hydrogenation reaction solution were used as detection targets. An octadecyl-bonded silica column with ultra-high purity spherical fully porous silica as the matrix was used for isocratic elution with a single mobile phase. The mobile phase was prepared as follows: ammonium acetate and disodium ethylenediaminetetraacetate were weighed at a mass ratio of 5-6:1, dissolved in 3300 mL of 0.01 M HCl, then 30 mL of triethylamine and 555 mL of acetonitrile were added, and the pH was adjusted to 9.07 with glacial acetic acid. After mixing, the mixture was filtered through a mixed microporous membrane. The mobile phase achieved separation of the three target components within 10 min, and the progress of the hydrogenation reaction was determined in real time by the change in component content.
2. The method for rapidly determining the reaction progress of doxycycline hydrochloride preparation process using HPLC with hydrogenation reaction solution as the detection target, as described in claim 1, is characterized in that: When the percentage of metacycline in the hydrogenation reaction solution is ≤0.20%, the hydrogenation reaction is considered to have reached the endpoint and is terminated. If the percentage of metacycline is >0.20%, the hydrogenation reaction continues, and the reaction time is extended according to the residual metacycline content, and the reaction is retested until the percentage of metacycline is ≤0.20%.
3. The method for rapidly determining the reaction progress of doxycycline hydrochloride preparation process using HPLC with the hydrogenation reaction solution as the detection target, as described in claim 2, is characterized in that: The retesting process after extending the reaction time is as follows: for metacycline content of 0.2%~0.5%, extend the reaction time by 1 hour; for metacycline content of 0.5%~1.5%, extend the reaction time by 2 hours; for metacycline content of 1.5%~2.5%, extend the reaction time by 3 hours; for metacycline content >2.5%, continue the reaction and resample for retesting.
4. The method for rapidly determining the reaction progress of doxycycline hydrochloride preparation process using HPLC with the hydrogenation reaction solution as the detection target, as described in claim 1, is characterized in that... Includes the following steps: 1) Prepare the test solution and set aside; 2) Set up liquid chromatography conditions using an octadecyl-bonded silica column with ultra-high purity spherical fully porous silica as the matrix, and perform isocratic elution; wherein, the mobile phase is prepared as follows: weigh ammonium acetate and disodium ethylenediaminetetraacetate at a mass ratio of 5~6:1, add 3300mL of 0.01M HCl, dissolve, add 30mL of triethylamine, add 555mL of acetonitrile, add 2.5mL of glacial acetic acid to adjust the pH to 9.07 at room temperature, mix, and filter with a 0.45μm organic phase / aqueous phase compatible mixed microporous membrane; 3) Accurately measure the test solution, inject it into the liquid chromatograph, and record the chromatogram.
5. The method for rapidly determining the reaction progress of doxycycline hydrochloride preparation process using HPLC with the hydrogenation reaction solution as the detection target, as described in claim 4, is characterized in that: In step 1), the test solution is prepared as follows: 20 mg of hydrogenation reaction solution is transferred to a 50 mL volumetric flask, 0.5 mL of acetonitrile and 5 mL of 0.01 M HCl are added and dissolved by sonication, and then diluted to volume with 0.01 M HCl.
6. The method for rapidly determining the reaction progress of doxycycline hydrochloride preparation process using HPLC with the hydrogenation reaction solution as the detection target, as described in claim 4, is characterized in that: In step 2), the chromatographic column is a Zafex Luxthylfex XT-C18 with a size of 250×4.6mm and a packing particle size of 5μm.
7. The method for rapidly determining the reaction progress of doxycycline hydrochloride preparation process using HPLC with the hydrogenation reaction solution as the detection target, as described in claim 4, is characterized in that: In step 2), the column temperature is 45℃ and the flow rate is 1.0 mL / min.
8. The method for rapidly determining the reaction progress of doxycycline hydrochloride preparation process using HPLC with hydrogenation reaction solution as the detection target, as described in claim 4, is characterized in that: In step 2), the detection wavelength is 280nm.
9. The method for rapidly determining the reaction progress of doxycycline hydrochloride preparation process using HPLC with hydrogenation reaction solution as the detection target, as described in claim 4, is characterized in that: In step 2), the injection volume is 20 μL.
10. The method for rapidly determining the reaction progress of doxycycline hydrochloride preparation process using HPLC with hydrogenation reaction solution as the detection target according to claim 4, characterized in that: The linear regression equation for doxycycline in the concentration range of 20%–120% is y = 590.5743x - 1.1609, with a correlation coefficient R0. 2 ≥0.999.
Citation Information
Patent Citations
Preparation method of doxycycline hydrochloride
CN108440330A
Method for preparing doxycycline sulfosalicylate through hydrogenation of metacycline p-toluenesulfonate
CN115028546A
